# Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

> **NCT01397461** · PHASE3 · COMPLETED · sponsor: **Ferrer Internacional S.A.** · enrollment: 465 (actual)

## Conditions studied

- Impetigo

## Interventions

- **DRUG:** ozenoxacin placebo
- **DRUG:** retapamulin 1% ointment
- **DRUG:** ozenoxacin 1% cream

## Key facts

- **NCT ID:** NCT01397461
- **Lead sponsor:** Ferrer Internacional S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 465 (ACTUAL)
- **Last updated:** 2016-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01397461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01397461, "Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01397461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*